BioCentury
ARTICLE | Company News

Ranbaxy, Sun Pharmaceutical deal

May 4, 2015 7:00 AM UTC

Sun completed its acquisition of Ranbaxy. Ranbaxy shareholders will receive 0.8 shares of Sun for every share of Ranbaxy held. The transaction values Ranbaxy at Rs352.5 billion ($5.5 billion) based on...